Elastic NV vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? Elastic NV trades at $91.22 (market cap $9.67B), while Ionis Pharmaceuticals Inc. Common Stock trades at $44.17 (market cap $7.10B). The key difference: Elastic NV is the larger of the two by market cap, and Elastic NV is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Elastic NV for 11 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.
| ESTC | IONS | |
|---|---|---|
Market Cap | $9.67B | $7.10B |
Volume | 1,592,425 | 2,027,457 |
Sector | Technology | Health |
52-Week High | $99.91 | $86.50 |
52-Week Low | $43.30 | $42.38 |
Typical Hold Time | 11 Days | 0 Days |
Enterprise Value | $8.80B | $6.66B |
Signals from Pluang's Aura AI — not financial advice
Elastic (ESTC) trades at $90.9, down 3.63% on the day, with a bullish technical signal and strong analyst support. The company reported three consecutive quarterly EPS beats and is expanding its AI and observability platform, as highlighted by recent product launches. Revenue growth is robust, projected to rise from $1.48B in 2025 to $1.8B in 2026, with net income turning positive to $376M.
The outlook is positive, driven by product innovation and earnings momentum, but risks include high valuation multiples and competitive pressures. Wall Street consensus is a Buy with a $83.18 price target, indicating potential upside from current levels amid steady institutional interest.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.
Read more on ESTC →Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →